 SOUTH SAN FRANCISCO, Calif., Nov. 04, 2021 GLOBE NEWSWIRE -- Nkarta, Inc. Nasdaq: NKTX, a biopharmaceutical company developing engineered natural killer NK cell therapies to treat cancer, today announced its participation at these upcoming investor conferences: 